Published in Pharmacol Rev on December 01, 1998
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (2000) 3.71
Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci U S A (1999) 3.15
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology (2012) 1.74
Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol (2001) 1.45
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat Rev Drug Discov (2013) 1.27
Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci U S A (2004) 1.27
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol (2012) 1.26
Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology (Berl) (2005) 1.18
Overview of glutamatergic neurotransmission in the nervous system. Pharmacol Biochem Behav (2011) 1.18
A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) (2006) 1.18
Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol (2004) 1.14
Neuronal release of D-serine: a physiological pathway controlling extracellular D-serine concentration. FASEB J (2010) 1.12
N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology (Berl) (2005) 1.11
D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons. J Physiol (2003) 1.08
Alcohol related changes in regulation of NMDA receptor functions. Curr Neuropharmacol (2008) 1.07
Aspartate racemase, generating neuronal D-aspartate, regulates adult neurogenesis. Proc Natl Acad Sci U S A (2010) 1.06
Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia. Drug Discov Today (2009) 1.05
Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J Physiol (2005) 1.04
Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain. J Biol Chem (2010) 1.01
Glycine transport inhibitors for the treatment of schizophrenia. Open Med Chem J (2010) 1.00
The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective. Philos Trans R Soc Lond B Biol Sci (2004) 0.99
Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol (2015) 0.97
A new strategy to decrease N-methyl-D-aspartate (NMDA) receptor coactivation: inhibition of D-serine synthesis by converting serine racemase into an eliminase. Proc Natl Acad Sci U S A (2001) 0.96
D-cycloserine facilitates synaptic plasticity but impairs glutamatergic neurotransmission in rat hippocampal slices. Br J Pharmacol (2003) 0.93
The glycine transporter 1 inhibitor SSR504734 enhances working memory performance in a continuous delayed alternation task in C57BL/6 mice. Psychopharmacology (Berl) (2008) 0.93
The role of inflammatory processes in Alzheimer's disease. Inflammopharmacology (2012) 0.92
A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice. J Neural Transm (Vienna) (2011) 0.91
D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window. Eur J Pharmacol (2009) 0.91
The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells. Neurochem Int (2009) 0.91
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2011) 0.91
Glutamate receptor composition of the post-synaptic density is altered in genetic mouse models of NMDA receptor hypo- and hyperfunction. Brain Res (2011) 0.90
N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport. Br J Pharmacol (2001) 0.90
NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats. Psychopharmacology (Berl) (2007) 0.90
The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition. J Pharmacol Exp Ther (2015) 0.89
D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats. Psychopharmacology (Berl) (2010) 0.89
The external globus pallidus: progress and perspectives. Eur J Neurosci (2016) 0.89
Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence. Neuropsychopharmacology (2010) 0.89
Novel NMDA receptor modulators: an update. Expert Opin Ther Pat (2012) 0.87
The discriminative stimulus effects of N-methyl-D-aspartate glycine-site ligands in NMDA antagonist-trained rats. Psychopharmacology (Berl) (2009) 0.86
Crystal structure of a homolog of mammalian serine racemase from Schizosaccharomyces pombe. J Biol Chem (2009) 0.86
Cytoprotection by glycine against ATP-depletion-induced injury is mediated by glycine receptor in renal cells. Biochem J (2005) 0.86
Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices. J Physiol (2004) 0.85
Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury. Dev Neurorehabil (2009) 0.85
Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates. Ann Neurol (2004) 0.85
Deletion of glycine transporter 1 (GlyT1) in forebrain neurons facilitates reversal learning: enhanced cognitive adaptability? Behav Neurosci (2009) 0.85
Role of glycine receptors in glycine-induced LTD in hippocampal CA1 pyramidal neurons. Neuropsychopharmacology (2011) 0.84
Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology (Berl) (2007) 0.84
Glycine and D: -serine, but not D: -cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801. Psychopharmacology (Berl) (2008) 0.83
ACS chemical neuroscience molecule spotlight on RG1678. ACS Chem Neurosci (2011) 0.83
Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site. J Biol Chem (2013) 0.83
NMDA receptor modulators: an updated patent review (2013-2014). Expert Opin Ther Pat (2014) 0.82
The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus. Neuroscience (2015) 0.82
Development of PET and SPECT probes for glutamate receptors. ScientificWorldJournal (2015) 0.81
Identification of a single amino acid in GluN1 that is critical for glycine-primed internalization of NMDA receptors. Mol Brain (2013) 0.80
Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls. Psychopharmacology (Berl) (2007) 0.80
The regulatory role of long-term depression in juvenile and adult mouse ocular dominance plasticity. Sci Rep (2011) 0.80
Role of altered structure and function of NMDA receptors in development of alcohol dependence. Curr Neuropharmacol (2005) 0.80
Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain. PLoS One (2011) 0.80
1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology (Berl) (2014) 0.79
The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review. Yonsei Med J (2008) 0.79
Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.79
A role for glutamate in subjective response to smoking and its action on inhibitory control. Psychopharmacology (Berl) (2011) 0.79
E-p-methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate. Br J Pharmacol (2002) 0.79
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review. Int J Neuropsychopharmacol (2016) 0.79
D-Cycloserine enhances conditioned taste aversion learning in rats. Pharmacol Biochem Behav (2007) 0.79
Voltage-dependent inhibition of recombinant NMDA receptor-mediated currents by 5-hydroxytryptamine. Br J Pharmacol (2005) 0.78
Heteromerization of ligand binding domains of N-methyl-D-aspartate receptor requires both coagonists, L-glutamate and glycine. Biochemistry (2015) 0.78
Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus. Neurotox Res (2011) 0.78
Sigma receptors [σRs]: biology in normal and diseased states. J Recept Signal Transduct Res (2015) 0.78
Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats. PLoS One (2014) 0.78
High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans. Psychopharmacology (Berl) (2007) 0.78
Selective Pharmacological Modulation of Pyramidal Neurons and Interneurons in the CA1 Region of the Rat Hippocampus. Front Pharmacol (2013) 0.78
Serine racemase: a key player in apoptosis and necrosis. Front Synaptic Neurosci (2014) 0.78
dsdA Does Not Affect Colonization of the Murine Urinary Tract by Escherichia coli CFT073. PLoS One (2015) 0.78
Cellular origin and regulation of D- and L-serine in in vitro and in vivo models of cerebral ischemia. J Cereb Blood Flow Metab (2014) 0.77
Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges. Front Cell Neurosci (2017) 0.76
Glycine induces bidirectional modifications in N-methyl-D-aspartate receptor-mediated synaptic responses in hippocampal CA1 neurons. J Biol Chem (2014) 0.76
Intact working memory in the absence of forebrain neuronal glycine transporter 1. Behav Brain Res (2012) 0.76
A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization. J Neural Transm (Vienna) (2007) 0.76
Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome. Pediatr Neurol (2015) 0.76
Stacking interaction and its role in kynurenic acid binding to glutamate ionotropic receptors. J Mol Model (2011) 0.76
Evidence for involvement of glial cell activity in the control of extracellular D-serine contents in the rat brain. J Neural Transm (Vienna) (2006) 0.76
Yokukansan, a traditional Japanese medicine, adjusts glutamate signaling in cultured keratinocytes. Biomed Res Int (2014) 0.76
Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats. Psychopharmacology (Berl) (2005) 0.76
Osmotic Edema Rapidly Increases Neuronal Excitability Through Activation of NMDA Receptor-Dependent Slow Inward Currents in Juvenile and Adult Hippocampus. ASN Neuro (2015) 0.76
Characterization of the binding of two novel glycine site antagonists to cloned NMDA receptors: evidence for two pharmacological classes of antagonists. Br J Pharmacol (2000) 0.76
Quantitative analysis of tetrapentylammonium-induced blockade of open N-methyl-D-aspartate channels. Biophys J (2000) 0.76
Palmitoylethanolamide inhibits glutamate release in rat cerebrocortical nerve terminals. Int J Mol Sci (2015) 0.75
Metabolic Changes Following Perinatal Asphyxia: Role of Astrocytes and Their Interaction with Neurons. Front Aging Neurosci (2016) 0.75
Neuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serine. Int J Physiol Pathophysiol Pharmacol (2013) 0.75
Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain. Br J Pharmacol (2001) 0.75
Stereocontrolled synthesis and pharmacological evaluation of azetidine-2,3-dicarboxylic acids at NMDA receptors. ChemMedChem (2009) 0.75
Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[11 C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([11 C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1. EJNMMI Res (2012) 0.75
Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo. Neurotox Res (2014) 0.75
Targeting glutamate to treat schizophrenia: lessons from recent clinical studies. Psychopharmacology (Berl) (2016) 0.75
The role of dopamine D1 and D3 receptors in N-methyl-D-aspartate (NMDA)/glycineB site-regulated complex cognitive behaviors following repeated morphine administration. Int J Neuropsychopharmacol (2017) 0.75
Antinociceptive effect of intracerebroventricular administration of D-serine on formalin-induced pain. J Anesth (2013) 0.75
Molecular electrostatic potentials in aromatic substituted 4-hydroxyquino-2-lones: glycine/NMDA receptor antagonists. J Mol Model (2008) 0.75
COMPLETE AURICULO-VENTRICULAR DISSOCIATION WITH HIGH VENTRICULAR RATE IN PAROXYSMAL TACHYCARDIA. Br Heart J (1943) 1.34
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies. Neurosci Biobehav Rev (1997) 1.27
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett (2001) 1.20
Haemodynamic effects of balloon septostomy in tricuspid atresia. Br Med J (1968) 1.10
Pulmonary artery banding and subsequent repair in ventricular septal defect. Br Heart J (1973) 1.08
The role of N-methylaspartate receptors in mediating responses of rat and cat spinal neurones to defined sensory stimuli. J Physiol (1987) 1.08
Pharmacodynamics of memantine: an update. Curr Neuropharmacol (2008) 1.03
Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br J Pharmacol (1996) 0.98
Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol (1996) 0.98
Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology (1997) 0.97
Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. Eur J Neurosci (2003) 0.97
Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats. Eur J Neurosci (1996) 0.96
Transposition of great arteries. A study of 65 infants followed for 1 to 4 years after balloon septostomy. Br Heart J (1971) 0.96
Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices. Neuropharmacology (1999) 0.95
Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity. Neuropharmacology (1995) 0.94
Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action. Neurotox Res (2000) 0.92
Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication. J Neural Transm (Vienna) (1999) 0.89
Learning deficits induced by chronic intraventricular infusion of quinolinic acid--protection by MK-801 and memantine. Eur J Pharmacol (1996) 0.88
Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones. Neuropharmacology (1999) 0.87
Comparison of mu, kappa and sigma preferring agonists for effects on spinal nociceptive and other responses in rats. Neuropeptides (1984) 0.86
Recurrence of aortic coarctation after operation in childhood. Br Med J (1966) 0.86
GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids (1998) 0.85
Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats. Br J Pharmacol (1991) 0.85
Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp. Neuropharmacology (1997) 0.84
Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine. Neuropharmacology (2007) 0.84
Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex. Nucl Med Biol (1998) 0.83
Amino-alkyl-cyclohexanes as a novel class of uncompetitive NMDA receptor antagonists. Curr Pharm Des (2002) 0.82
Synthesis and structure-affinity relationships of 1,3, 5-alkylsubstituted cyclohexylamines binding at NMDA receptor PCP site. Eur J Med Chem (2000) 0.82
Expression of early hippocampal CA1 LTP does not lead to changes in AMPA-EPSC kinetics or sensitivity to cyclothiazide. Pflugers Arch (1999) 0.82
Recurrent coarctation of the aorta. Am Heart J (1967) 0.81
Memantine selectively depresses NMDA receptor-mediated responses of ratspinal neurones in vivo. Neurosci Lett (1994) 0.80
NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization. Amino Acids (2000) 0.80
Autoradiographic and electrophysiological evidence for excitatory amino acid transmission in the periaqueductal gray projection to nucleus raphe magnus in the rat. Neurosci Lett (1988) 0.80
Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices. Neuropharmacology (2000) 0.80
Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. Br J Pharmacol (1996) 0.80
Anomalous left coronary artery. Report of an unusual case with spontaneous remission of symptoms. Br Heart J (1973) 0.79
Brain distribution of an uncompetitive NMDA receptor antagonist; comparison to its in vitro potency in electrophysiological studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.78
Chronic treatment with the uncompetitive NMDA receptor antagonist memantine influences the polyamine and glycine binding sites of the NMDA receptor complex in aged rats. J Neural Transm Park Dis Dement Sect (1995) 0.78
The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole. J Neural Transm (Vienna) (2008) 0.77
The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones. Neuropharmacology (2001) 0.77
Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studies. J Neural Transm Gen Sect (1995) 0.77
Zinc changes AMPA receptor properties: results of binding studies and patch clamp recordings. Neuropharmacology (1996) 0.77
A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization. J Neural Transm (Vienna) (2007) 0.76
Do kappa opioids mimic sigma agonists as amino acid antagonists? Neuropharmacology (1986) 0.76
Protection against post-ischaemic neuronal loss in gerbil hippocampal CA1 by glycineB and AMPA antagonists. Short communication. J Neural Transm (Vienna) (1997) 0.76
Traumatic Uraemia. Br Med J (1945) 0.76
Congenital mitral stenosis. Br Heart J (1967) 0.75
The Treatment of Acute Leukaemia in Adults with Cyclophosphamide. Postgrad Med J (1965) 0.75
GlycineB recognition site of NMDA receptors and its antagonists. Amino Acids (1998) 0.75
Transposition of the great arteries. A review of 37 cases after Mustard's operation. Thorax (1973) 0.75
Preparation for retirement. Practitioner (1978) 0.75
A novel series of 2-carboxytetrahydroquinolines provides new insights into the eastern region of glycine site NMDA antagonists. Arch Pharm (Weinheim) (2000) 0.75
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats. Pain (2001) 0.75
Fluorine-18 radiolabelling, biodistribution studies and preliminary PET evaluation of a new memantine derivative for imaging the NMDA receptor. J Recept Signal Transduct Res (1999) 0.75
Stomatitis in Childhood. Arch Dis Child (1940) 0.75
Twelve years follow-up after surgical correction of Fallot's tetralogy in childhood. Br Heart J (1972) 0.75
Reflex Action During General Surgical Anaesthesia. Ann Surg (1913) 0.75
Local opioid receptors mediating antinociception in inflammation: endogenous ligands. Prog Clin Biol Res (1990) 0.75